Singapore markets close in 51 minutes

Sichuan Kelun Pharmaceutical Co., Ltd. (002422.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
33.25-0.18 (-0.54%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 53.54B
Enterprise value 52.06B
Trailing P/E 19.32
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.34
Price/book (mrq)2.41
Enterprise value/revenue 2.36
Enterprise value/EBITDA 11.90

Trading information

Stock price history

Beta (5Y monthly) 0.04
52-week change 36.98%
S&P500 52-week change 327.84%
52-week high 335.49
52-week low 321.60
50-day moving average 331.03
200-day moving average 328.25

Share statistics

Avg vol (3-month) 316.61M
Avg vol (10-day) 314.47M
Shares outstanding 51.6B
Implied shares outstanding 61.6B
Float 81.01B
% held by insiders 132.89%
% held by institutions 120.08%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.62
Forward annual dividend yield 41.76%
Trailing annual dividend rate 30.80
Trailing annual dividend yield 32.39%
5-year average dividend yield 41.72
Payout ratio 435.61%
Dividend date 3N/A
Ex-dividend date 415 May 2023
Last split factor 220:10
Last split date 322 Jul 2015

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 12.11%
Operating margin (ttm)23.91%

Management effectiveness

Return on assets (ttm)6.35%
Return on equity (ttm)13.37%

Income statement

Revenue (ttm)22.04B
Revenue per share (ttm)14.90
Quarterly revenue growth (yoy)10.30%
Gross profit (ttm)N/A
EBITDA 4.93B
Net income avi to common (ttm)2.67B
Diluted EPS (ttm)1.73
Quarterly earnings growth (yoy)26.00%

Balance sheet

Total cash (mrq)6.83B
Total cash per share (mrq)4.46
Total debt (mrq)5.35B
Total debt/equity (mrq)20.67%
Current ratio (mrq)1.98
Book value per share (mrq)14.53

Cash flow statement

Operating cash flow (ttm)5.11B
Levered free cash flow (ttm)-324.26M